speb/financial-data huggingface dataset:
CRCL.L balance_sheet (annual, 2025-06-30) — Stockholders Equity: 3267000.00
CRCL.L balance_sheet (quarterly, 2025-06-30) — Stockholders Equity: 3267000.00
CRCL.L balance_sheet (annual, 2025-06-30) — Tangible Book Value: 3267000.00
CRCL.L balance_sheet (quarterly, 2025-06-30) — Tangible Book Value: 3267000.00
CRCL.L income_statement (annual, 2025-06-30) — Tax Effect Of Unusual Items: 0.00
CRCL.L income_statement (annual, 2025-06-30) — Tax Provision: 0.00
CRCL.L income_statement (annual, 2025-06-30) — Tax Rate For Calcs: 0.00
CRCL.L balance_sheet (annual, 2025-06-30) — Total Assets: 8313000.00
CRCL.L balance_sheet (quarterly, 2025-06-30) — Total Assets: 8313000.00
CRCL.L balance_sheet (annual, 2025-06-30) — Total Capitalization: 3267000.00
CRCL.L balance_sheet (quarterly, 2025-06-30) — Total Capitalization: 3267000.00
CRCL.L balance_sheet (annual, 2025-06-30) — Total Debt: 555000.00
CRCL.L balance_sheet (quarterly, 2025-06-30) — Total Debt: 555000.00
CRCL.L balance_sheet (annual, 2025-06-30) — Total Equity Gross Minority Interest: 3267000.00
CRCL.L balance_sheet (quarterly, 2025-06-30) — Total Equity Gross Minority Interest: 3267000.00
CRCL.L income_statement (annual, 2025-06-30) — Total Expenses: 3250000.00
CRCL.L balance_sheet (annual, 2025-06-30) — Total Liabilities Net Minority Interest: 5046000.00
CRCL.L balance_sheet (quarterly, 2025-06-30) — Total Liabilities Net Minority Interest: 5046000.00
CRCL.L balance_sheet (annual, 2025-06-30) — Total Non Current Assets: 7090000.00
CRCL.L balance_sheet (quarterly, 2025-06-30) — Total Non Current Assets: 7090000.00
CRCL.L balance_sheet (annual, 2025-06-30) — Total Non Current Liabilities Net Minority Interest: 0.00
CRCL.L balance_sheet (quarterly, 2025-06-30) — Total Non Current Liabilities Net Minority Interest: 0.00
CRCL.L income_statement (annual, 2025-06-30) — Total Unusual Items: -284000.00
CRCL.L income_statement (annual, 2025-06-30) — Total Unusual Items Excluding Goodwill: -284000.00
CRCL.L balance_sheet (annual, 2025-06-30) — Working Capital: -3823000.00
CRCL.L balance_sheet (quarterly, 2025-06-30) — Working Capital: -3823000.00
CRCL.L income_statement (annual, 2025-06-30) — Write Off: 105000.00
CRCL.L balance_sheet (quarterly, 2025-12-31) — Accounts Payable: 2190000.00
CRCL.L balance_sheet (quarterly, 2025-12-31) — Accounts Receivable: 229000.00
CRCL.L balance_sheet (quarterly, 2025-12-31) — Additional Paid In Capital: 42764000.00
CRCL.L balance_sheet (quarterly, 2025-12-31) — Assets Held For Sale Current: 0.00
CRCL.L balance_sheet (quarterly, 2025-12-31) — Available For Sale Securities: 1000.00
CRCL.L balance_sheet (quarterly, 2025-12-31) — Capital Stock: 852000.00
CRCL.L balance_sheet (quarterly, 2025-12-31) — Cash And Cash Equivalents: 5183000.00
CRCL.L balance_sheet (quarterly, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 5183000.00
CRCL.L balance_sheet (quarterly, 2025-12-31) — Common Stock: 852000.00
CRCL.L balance_sheet (quarterly, 2025-12-31) — Common Stock Equity: 8882000.00
CRCL.L balance_sheet (quarterly, 2025-12-31) — Current Assets: 5412000.00
CRCL.L balance_sheet (quarterly, 2025-12-31) — Current Debt: 16000.00
CRCL.L balance_sheet (quarterly, 2025-12-31) — Current Debt And Capital Lease Obligation: 16000.00
CRCL.L balance_sheet (quarterly, 2025-12-31) — Current Liabilities: 2206000.00
CRCL.L balance_sheet (quarterly, 2025-12-31) — Invested Capital: 8898000.00
CRCL.L balance_sheet (quarterly, 2025-12-31) — Investmentin Financial Assets: 1000.00
CRCL.L balance_sheet (quarterly, 2025-12-31) — Net PPE: 7984000.00
CRCL.L balance_sheet (quarterly, 2025-12-31) — Net Tangible Assets: 8882000.00
CRCL.L balance_sheet (quarterly, 2025-12-31) — Ordinary Shares Number: 8515475997.00
CRCL.L balance_sheet (quarterly, 2025-12-31) — Other Equity Interest: 2707000.00
CRCL.L balance_sheet (quarterly, 2025-12-31) — Payables: 2190000.00
CRCL.L balance_sheet (quarterly, 2025-12-31) — Retained Earnings: -40686000.00
CRCL.L balance_sheet (quarterly, 2025-12-31) — Share Issued: 8515475997.00
CRCL.L balance_sheet (quarterly, 2025-12-31) — Stockholders Equity: 8882000.00
CRCL.L balance_sheet (quarterly, 2025-12-31) — Tangible Book Value: 8882000.00
CRCL.L balance_sheet (quarterly, 2025-12-31) — Total Assets: 13658000.00
CRCL.L balance_sheet (quarterly, 2025-12-31) — Total Capitalization: 8882000.00
CRCL.L balance_sheet (quarterly, 2025-12-31) — Total Debt: 16000.00
CRCL.L balance_sheet (quarterly, 2025-12-31) — Total Equity Gross Minority Interest: 8882000.00
CRCL.L balance_sheet (quarterly, 2025-12-31) — Total Liabilities Net Minority Interest: 4776000.00
CRCL.L balance_sheet (quarterly, 2025-12-31) — Total Non Current Assets: 8246000.00
CRCL.L balance_sheet (quarterly, 2025-12-31) — Total Non Current Liabilities Net Minority Interest: 2570000.00
CRCL.L balance_sheet (quarterly, 2025-12-31) — Tradeand Other Payables Non Current: 2570000.00
CRCL.L balance_sheet (quarterly, 2025-12-31) — Working Capital: 3206000.00
CRCT cash_flow (annual, 2021-12-31) — Common Stock Issuance: 262007000.00
CRCT balance_sheet (annual, 2021-12-31) — Finished Goods: 433987000.00
CRCT cash_flow (annual, 2021-12-31) — Gain Loss On Sale Of PPE: -2000.00
CRCT balance_sheet (annual, 2021-12-31) — Goodwill And Other Intangible Assets: 1520000.00
CRCT cash_flow (annual, 2021-12-31) — Interest Paid Supplemental Data: 14000.00
CRCT cash_flow (annual, 2021-12-31) — Issuance Of Capital Stock: 262007000.00
CRCT cash_flow (annual, 2021-12-31) — Issuance Of Debt: 0.00
CRCT cash_flow (annual, 2021-12-31) — Long Term Debt Payments: 0.00
CRCT cash_flow (annual, 2021-12-31) — Net Issuance Payments Of Debt: 0.00
CRCT cash_flow (annual, 2021-12-31) — Net Long Term Debt Issuance: 0.00
CRCT cash_flow (annual, 2021-12-31) — Net Short Term Debt Issuance: 0.00
CRCT balance_sheet (annual, 2021-12-31) — Other Intangible Assets: 1520000.00
CRCT balance_sheet (annual, 2021-12-31) — Prepaid Assets: 32820000.00
CRCT balance_sheet (annual, 2021-12-31) — Raw Materials: 20187000.00
CRCT cash_flow (annual, 2021-12-31) — Repayment Of Debt: 0.00
CRCT cash_flow (annual, 2021-12-31) — Short Term Debt Issuance: 0.00
CRCT cash_flow (annual, 2021-12-31) — Short Term Debt Payments: 0.00
CRCT income_statement (annual, 2022-12-31) — +Operating Expense: 269940000.00
CRCT income_statement (annual, 2022-12-31) — +Total Revenue: 886296000.00
CRCT balance_sheet (annual, 2022-12-31) — Accounts Payable: 63195000.00
CRCT balance_sheet (annual, 2022-12-31) — Accounts Receivable: 128437000.00
CRCT balance_sheet (annual, 2022-12-31) — Accumulated Depreciation: -80050000.00
CRCT balance_sheet (annual, 2022-12-31) — Additional Paid In Capital: 672990000.00
CRCT cash_flow (annual, 2022-12-31) — Asset Impairment Charge: 2858000.00
CRCT income_statement (annual, 2022-12-31) — Basic Average Shares: 214458284.00
CRCT income_statement (annual, 2022-12-31) — Basic EPS: 0.28
CRCT cash_flow (annual, 2022-12-31) — Beginning Cash Position: 241597000.00
CRCT balance_sheet (annual, 2022-12-31) — Buildings And Improvements: 17078000.00
CRCT cash_flow (annual, 2022-12-31) — Capital Expenditure: -33771000.00
CRCT balance_sheet (annual, 2022-12-31) — Capital Lease Obligations: 19371000.00
CRCT balance_sheet (annual, 2022-12-31) — Capital Stock: 220000.00
CRCT balance_sheet (annual, 2022-12-31) — Cash And Cash Equivalents: 224943000.00
CRCT balance_sheet (annual, 2022-12-31) — Cash Cash Equivalents And Short Term Investments: 299199000.00
CRCT cash_flow (annual, 2022-12-31) — Cash Dividends Paid: 0.00
CRCT balance_sheet (annual, 2022-12-31) — Cash Equivalents: 69484000.00
CRCT balance_sheet (annual, 2022-12-31) — Cash Financial: 155459000.00
CRCT cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Financing Activities: -26247000.00
CRCT cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Investing Activities: -107869000.00
CRCT cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Operating Activities: 117683000.00
CRCT cash_flow (annual, 2022-12-31) — Change In Account Payable: -139845000.00
CRCT cash_flow (annual, 2022-12-31) — Change In Accrued Expense: -2137000.00
CRCT cash_flow (annual, 2022-12-31) — Change In Inventory: 63085000.00
CRCT cash_flow (annual, 2022-12-31) — Change In Other Current Assets: -51000.00
CRCT cash_flow (annual, 2022-12-31) — Change In Other Current Liabilities: -5096000.00
CRCT cash_flow (annual, 2022-12-31) — Change In Other Working Capital: 3252000.00
CRCT cash_flow (annual, 2022-12-31) — Change In Payable: -139845000.00
CRCT cash_flow (annual, 2022-12-31) — Change In Payables And Accrued Expense: -141982000.00
CRCT cash_flow (annual, 2022-12-31) — Change In Prepaid Assets: 8807000.00
CRCT cash_flow (annual, 2022-12-31) — Change In Receivables: 63696000.00
CRCT cash_flow (annual, 2022-12-31) — Change In Working Capital: -8289000.00
CRCT cash_flow (annual, 2022-12-31) — Changes In Account Receivables: 63696000.00
CRCT cash_flow (annual, 2022-12-31) — Changes In Cash: -16433000.00
CRCT balance_sheet (annual, 2022-12-31) — Common Stock: 220000.00
CRCT cash_flow (annual, 2022-12-31) — Common Stock Dividend Paid: 0.00
CRCT balance_sheet (annual, 2022-12-31) — Common Stock Equity: 672735000.00
CRCT cash_flow (annual, 2022-12-31) — Common Stock Issuance: 0.00
CRCT cash_flow (annual, 2022-12-31) — Common Stock Payments: -18580000.00
CRCT balance_sheet (annual, 2022-12-31) — Construction In Progress: 13134000.00
CRCT income_statement (annual, 2022-12-31) — Cost Of Revenue: 536403000.00
CRCT balance_sheet (annual, 2022-12-31) — Current Accrued Expenses: 69775000.00
CRCT balance_sheet (annual, 2022-12-31) — Current Assets: 811262000.00
CRCT balance_sheet (annual, 2022-12-31) — Current Capital Lease Obligation: 5436000.00
CRCT balance_sheet (annual, 2022-12-31) — Current Debt And Capital Lease Obligation: 5436000.00
CRCT balance_sheet (annual, 2022-12-31) — Current Deferred Liabilities: 34869000.00
CRCT balance_sheet (annual, 2022-12-31) — Current Deferred Revenue: 34869000.00
CRCT balance_sheet (annual, 2022-12-31) — Current Liabilities: 254056000.00
CRCT cash_flow (annual, 2022-12-31) — Deferred Income Tax: -20461000.00
CRCT cash_flow (annual, 2022-12-31) — Deferred Tax: -20461000.00
CRCT cash_flow (annual, 2022-12-31) — Depreciation Amortization Depletion: 26957000.00
CRCT cash_flow (annual, 2022-12-31) — Depreciation And Amortization: 26957000.00
CRCT income_statement (annual, 2022-12-31) — Diluted Average Shares: 220588789.00
CRCT income_statement (annual, 2022-12-31) — Diluted EPS: 0.28
CRCT income_statement (annual, 2022-12-31) — Diluted NI Availto Com Stockholders: 60666000.00
CRCT balance_sheet (annual, 2022-12-31) — Dividends Payable: 80781000.00
CRCT income_statement (annual, 2022-12-31) — EBIT: 82270000.00
CRCT income_statement (annual, 2022-12-31) — EBITDA: 109227000.00
CRCT cash_flow (annual, 2022-12-31) — Effect Of Exchange Rate Changes: -221000.00
CRCT cash_flow (annual, 2022-12-31) — End Cash Position: 224943000.00
CRCT cash_flow (annual, 2022-12-31) — Financing Cash Flow: -26247000.00
CRCT cash_flow (annual, 2022-12-31) — Free Cash Flow: 83912000.00
CRCT balance_sheet (annual, 2022-12-31) — Gains Losses Not Affecting Retained Earnings: -475000.00
CRCT income_statement (annual, 2022-12-31) — General And Administrative Expense: 62647000.00
CRCT balance_sheet (annual, 2022-12-31) — Goodwill And Other Intangible Assets: 760000.00
CRCT balance_sheet (annual, 2022-12-31) — Gross Accounts Receivable: 128437000.00
CRCT balance_sheet (annual, 2022-12-31) — Gross PPE: 160535000.00
CRCT income_statement (annual, 2022-12-31) — Gross Profit: 349893000.00
CRCT cash_flow (annual, 2022-12-31) — Income Tax Paid Supplemental Data: 28916000.00
CRCT income_statement (annual, 2022-12-31) — Interest Expense: 289000.00
CRCT income_statement (annual, 2022-12-31) — Interest Expense Non Operating: 289000.00
CRCT income_statement (annual, 2022-12-31) — Interest Income: 1809000.00
CRCT income_statement (annual, 2022-12-31) — Interest Income Non Operating: 1809000.00
CRCT cash_flow (annual, 2022-12-31) — Interest Paid Supplemental Data: 0.00
CRCT balance_sheet (annual, 2022-12-31) — Inventory: 351682000.00
CRCT balance_sheet (annual, 2022-12-31) — Invested Capital: 672735000.00
CRCT cash_flow (annual, 2022-12-31) — Investing Cash Flow: -107869000.00
CRCT cash_flow (annual, 2022-12-31) — Issuance Of Capital Stock: 0.00
CRCT cash_flow (annual, 2022-12-31) — Issuance Of Debt: 0.00
CRCT balance_sheet (annual, 2022-12-31) — Leases: 5057000.00
CRCT balance_sheet (annual, 2022-12-31) — Long Term Capital Lease Obligation: 13935000.00
CRCT balance_sheet (annual, 2022-12-31) — Long Term Debt And Capital Lease Obligation: 13935000.00
CRCT cash_flow (annual, 2022-12-31) — Long Term Debt Payments: 0.00
CRCT balance_sheet (annual, 2022-12-31) — Machinery Furniture Equipment: 89870000.00
CRCT cash_flow (annual, 2022-12-31) — Net Common Stock Issuance: -18580000.00
CRCT cash_flow (annual, 2022-12-31) — Net Foreign Currency Exchange Gain Loss: -1040000.00
CRCT income_statement (annual, 2022-12-31) — Net Income: 60666000.00
CRCT income_statement (annual, 2022-12-31) — Net Income Common Stockholders: 60666000.00
CRCT income_statement (annual, 2022-12-31) — Net Income Continuous Operations: 60666000.00
CRCT income_statement (annual, 2022-12-31) — Net Income From Continuing And Discontinued Operation: 60666000.00
CRCT income_statement (annual, 2022-12-31) — Net Income From Continuing Operation Net Minority Interest: 60666000.00
CRCT cash_flow (annual, 2022-12-31) — Net Income From Continuing Operations: 60666000.00
CRCT income_statement (annual, 2022-12-31) — Net Income Including Noncontrolling Interests: 60666000.00
CRCT income_statement (annual, 2022-12-31) — Net Interest Income: 1520000.00
CRCT cash_flow (annual, 2022-12-31) — Net Investment Purchase And Sale: -74098000.00
CRCT cash_flow (annual, 2022-12-31) — Net Issuance Payments Of Debt: 0.00
CRCT cash_flow (annual, 2022-12-31) — Net Long Term Debt Issuance: 0.00
CRCT income_statement (annual, 2022-12-31) — Net Non Operating Interest Income Expense: 1520000.00
CRCT cash_flow (annual, 2022-12-31) — Net Other Financing Charges: -7698000.00
CRCT balance_sheet (annual, 2022-12-31) — Net PPE: 80485000.00
CRCT cash_flow (annual, 2022-12-31) — Net PPE Purchase And Sale: -33771000.00
CRCT cash_flow (annual, 2022-12-31) — Net Short Term Debt Issuance: 0.00
CRCT balance_sheet (annual, 2022-12-31) — Net Tangible Assets: 671975000.00
CRCT balance_sheet (annual, 2022-12-31) — Non Current Deferred Assets: 23819000.00
CRCT balance_sheet (annual, 2022-12-31) — Non Current Deferred Liabilities: 3789000.00
CRCT balance_sheet (annual, 2022-12-31) — Non Current Deferred Revenue: 3789000.00
CRCT balance_sheet (annual, 2022-12-31) — Non Current Deferred Taxes Assets: 23819000.00
CRCT income_statement (annual, 2022-12-31) — Normalized EBITDA: 109227000.00
CRCT income_statement (annual, 2022-12-31) — Normalized Income: 60666000.00
CRCT cash_flow (annual, 2022-12-31) — Operating Cash Flow: 117683000.00
CRCT cash_flow (annual, 2022-12-31) — Operating Gains Losses: -1040000.00
CRCT income_statement (annual, 2022-12-31) — Operating Income: 79953000.00
CRCT income_statement (annual, 2022-12-31) — Operating Revenue: 886296000.00
CRCT balance_sheet (annual, 2022-12-31) — Ordinary Shares Number: 219656587.00
CRCT balance_sheet (annual, 2022-12-31) — Other Current Assets: 23842000.00
CRCT balance_sheet (annual, 2022-12-31) — Other Equity Adjustments: -475000.00
CRCT income_statement (annual, 2022-12-31) — Other Gand A: 62647000.00
CRCT income_statement (annual, 2022-12-31) — Other Income Expense: 508000.00
CRCT balance_sheet (annual, 2022-12-31) — Other Intangible Assets: 760000.00
CRCT cash_flow (annual, 2022-12-31) — Other Non Cash Items: 4405000.00
CRCT balance_sheet (annual, 2022-12-31) — Other Non Current Assets: 33301000.00
CRCT balance_sheet (annual, 2022-12-31) — Other Non Current Liabilities: 5112000.00
CRCT income_statement (annual, 2022-12-31) — Other Non Operating Income Expenses: 508000.00
CRCT balance_sheet (annual, 2022-12-31) — Other Properties: 35396000.00
CRCT balance_sheet (annual, 2022-12-31) — Other Receivables: 8550000.00
CRCT balance_sheet (annual, 2022-12-31) — Other Short Term Investments: 74256000.00
CRCT balance_sheet (annual, 2022-12-31) — Payables: 143976000.00
CRCT balance_sheet (annual, 2022-12-31) — Payables And Accrued Expenses: 213751000.00
CRCT balance_sheet (annual, 2022-12-31) — Preferred Stock: 0.00
CRCT income_statement (annual, 2022-12-31) — Pretax Income: 81981000.00
CRCT cash_flow (annual, 2022-12-31) — Proceeds From Stock Option Exercised: 31000.00
CRCT balance_sheet (annual, 2022-12-31) — Properties: 0.00
CRCT cash_flow (annual, 2022-12-31) — Provisionand Write Offof Assets: 11466000.00
CRCT cash_flow (annual, 2022-12-31) — Purchase Of Investment: -180112000.00
CRCT cash_flow (annual, 2022-12-31) — Purchase Of PPE: -33771000.00
CRCT balance_sheet (annual, 2022-12-31) — Receivables: 136539000.00
CRCT balance_sheet (annual, 2022-12-31) — Receivables Adjustments Allowances: -448000.00
CRCT income_statement (annual, 2022-12-31) — Reconciled Cost Of Revenue: 536403000.00
CRCT income_statement (annual, 2022-12-31) — Reconciled Depreciation: 26957000.00
CRCT cash_flow (annual, 2022-12-31) — Repayment Of Debt: 0.00
CRCT cash_flow (annual, 2022-12-31) — Repurchase Of Capital Stock: -18580000.00
CRCT income_statement (annual, 2022-12-31) — Research And Development: 76914000.00
CRCT balance_sheet (annual, 2022-12-31) — Retained Earnings: 0.00
CRCT cash_flow (annual, 2022-12-31) — Sale Of Investment: 106014000.00
CRCT income_statement (annual, 2022-12-31) — Selling And Marketing Expense: 130379000.00
CRCT income_statement (annual, 2022-12-31) — Selling General And Administration: 193026000.00
CRCT balance_sheet (annual, 2022-12-31) — Share Issued: 219656587.00
CRCT cash_flow (annual, 2022-12-31) — Short Term Debt Issuance: 0.00
CRCT cash_flow (annual, 2022-12-31) — Short Term Debt Payments: 0.00
CRCT cash_flow (annual, 2022-12-31) — Stock Based Compensation: 41121000.00
CRCT balance_sheet (annual, 2022-12-31) — Stockholders Equity: 672735000.00
CRCT balance_sheet (annual, 2022-12-31) — Tangible Book Value: 671975000.00
CRCT income_statement (annual, 2022-12-31) — Tax Effect Of Unusual Items: 0.00
CRCT income_statement (annual, 2022-12-31) — Tax Provision: 21315000.00
CRCT income_statement (annual, 2022-12-31) — Tax Rate For Calcs: 0.26
CRCT balance_sheet (annual, 2022-12-31) — Total Assets: 949627000.00
CRCT balance_sheet (annual, 2022-12-31) — Total Capitalization: 672735000.00
CRCT balance_sheet (annual, 2022-12-31) — Total Debt: 19371000.00
CRCT balance_sheet (annual, 2022-12-31) — Total Equity Gross Minority Interest: 672735000.00
CRCT income_statement (annual, 2022-12-31) — Total Expenses: 806343000.00
CRCT balance_sheet (annual, 2022-12-31) — Total Liabilities Net Minority Interest: 276892000.00
CRCT balance_sheet (annual, 2022-12-31) — Total Non Current Assets: 138365000.00
CRCT balance_sheet (annual, 2022-12-31) — Total Non Current Liabilities Net Minority Interest: 22836000.00
CRCT income_statement (annual, 2022-12-31) — Total Operating Income As Reported: 79953000.00
CRCT balance_sheet (annual, 2022-12-31) — Working Capital: 557206000.00
CRCT income_statement (annual, 2023-12-31) — +Operating Expense: 273308000.00
CRCT income_statement (annual, 2023-12-31) — +Total Revenue: 765147000.00
CRCT balance_sheet (annual, 2023-12-31) — Accounts Payable: 76860000.00
CRCT balance_sheet (annual, 2023-12-31) — Accounts Receivable: 100070000.00
CRCT balance_sheet (annual, 2023-12-31) — Accumulated Depreciation: -102840000.00
CRCT balance_sheet (annual, 2023-12-31) — Additional Paid In Capital: 505864000.00
CRCT cash_flow (annual, 2023-12-31) — Asset Impairment Charge: 11673000.00
CRCT income_statement (annual, 2023-12-31) — Basic Average Shares: 216892525.00
CRCT income_statement (annual, 2023-12-31) — Basic EPS: 0.25
CRCT cash_flow (annual, 2023-12-31) — Beginning Cash Position: 224943000.00
CRCT balance_sheet (annual, 2023-12-31) — Buildings And Improvements: 12353000.00
CRCT cash_flow (annual, 2023-12-31) — Capital Expenditure: -23717000.00
CRCT balance_sheet (annual, 2023-12-31) — Capital Lease Obligations: 14168000.00
CRCT balance_sheet (annual, 2023-12-31) — Capital Stock: 218000.00
CRCT balance_sheet (annual, 2023-12-31) — Cash And Cash Equivalents: 142187000.00
CRCT balance_sheet (annual, 2023-12-31) — Cash Cash Equivalents And Short Term Investments: 245139000.00
CRCT cash_flow (annual, 2023-12-31) — Cash Dividends Paid: -294130000.00
CRCT balance_sheet (annual, 2023-12-31) — Cash Equivalents: 97378000.00
CRCT balance_sheet (annual, 2023-12-31) — Cash Financial: 44809000.00
CRCT cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Financing Activities: -322185000.00
CRCT cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Investing Activities: -48778000.00
CRCT cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Operating Activities: 288097000.00
CRCT cash_flow (annual, 2023-12-31) — Change In Account Payable: 13535000.00
CRCT cash_flow (annual, 2023-12-31) — Change In Accrued Expense: 7761000.00
CRCT cash_flow (annual, 2023-12-31) — Change In Inventory: 78376000.00
CRCT cash_flow (annual, 2023-12-31) — Change In Other Current Assets: 869000.00
CRCT cash_flow (annual, 2023-12-31) — Change In Other Current Liabilities: -5423000.00
CRCT cash_flow (annual, 2023-12-31) — Change In Other Working Capital: 4577000.00
CRCT cash_flow (annual, 2023-12-31) — Change In Payable: 13535000.00
CRCT cash_flow (annual, 2023-12-31) — Change In Payables And Accrued Expense: 21296000.00
CRCT cash_flow (annual, 2023-12-31) — Change In Prepaid Assets: 4204000.00
CRCT cash_flow (annual, 2023-12-31) — Change In Receivables: 23500000.00
CRCT cash_flow (annual, 2023-12-31) — Change In Working Capital: 127399000.00
CRCT cash_flow (annual, 2023-12-31) — Changes In Account Receivables: 23500000.00
CRCT cash_flow (annual, 2023-12-31) — Changes In Cash: -82866000.00
CRCT balance_sheet (annual, 2023-12-31) — Common Stock: 218000.00
CRCT cash_flow (annual, 2023-12-31) — Common Stock Dividend Paid: -294130000.00
CRCT balance_sheet (annual, 2023-12-31) — Common Stock Equity: 534873000.00
CRCT cash_flow (annual, 2023-12-31) — Common Stock Issuance: 0.00
CRCT cash_flow (annual, 2023-12-31) — Common Stock Payments: -20332000.00
CRCT balance_sheet (annual, 2023-12-31) — Construction In Progress: 1504000.00
CRCT income_statement (annual, 2023-12-31) — Cost Of Revenue: 421854000.00
CRCT balance_sheet (annual, 2023-12-31) — Current Accrued Expenses: 71933000.00
CRCT balance_sheet (annual, 2023-12-31) — Current Assets: 619969000.00
CRCT balance_sheet (annual, 2023-12-31) — Current Capital Lease Obligation: 5230000.00
CRCT balance_sheet (annual, 2023-12-31) — Current Debt And Capital Lease Obligation: 5230000.00
CRCT balance_sheet (annual, 2023-12-31) — Current Deferred Liabilities: 40304000.00
CRCT balance_sheet (annual, 2023-12-31) — Current Deferred Revenue: 40304000.00
CRCT balance_sheet (annual, 2023-12-31) — Current Liabilities: 196464000.00
CRCT cash_flow (annual, 2023-12-31) — Deferred Income Tax: -11238000.00
CRCT cash_flow (annual, 2023-12-31) — Deferred Tax: -11238000.00
CRCT cash_flow (annual, 2023-12-31) — Depreciation Amortization Depletion: 30039000.00
CRCT cash_flow (annual, 2023-12-31) — Depreciation And Amortization: 30039000.00
CRCT income_statement (annual, 2023-12-31) — Diluted Average Shares: 219722063.00
CRCT income_statement (annual, 2023-12-31) — Diluted EPS: 0.24
CRCT income_statement (annual, 2023-12-31) — Diluted NI Availto Com Stockholders: 53636000.00
CRCT balance_sheet (annual, 2023-12-31) — Dividends Payable: 2137000.00
CRCT income_statement (annual, 2023-12-31) — EBIT: 80106000.00
CRCT income_statement (annual, 2023-12-31) — EBITDA: 110145000.00
CRCT cash_flow (annual, 2023-12-31) — Effect Of Exchange Rate Changes: 110000.00
CRCT cash_flow (annual, 2023-12-31) — End Cash Position: 142187000.00
CRCT cash_flow (annual, 2023-12-31) — Financing Cash Flow: -322185000.00
CRCT cash_flow (annual, 2023-12-31) — Free Cash Flow: 264380000.00
CRCT balance_sheet (annual, 2023-12-31) — Gains Losses Not Affecting Retained Earnings: 277000.00
CRCT income_statement (annual, 2023-12-31) — General And Administrative Expense: 85091000.00
CRCT balance_sheet (annual, 2023-12-31) — Goodwill And Other Intangible Assets: 0.00
CRCT balance_sheet (annual, 2023-12-31) — Gross Accounts Receivable: 100070000.00
CRCT balance_sheet (annual, 2023-12-31) — Gross PPE: 162807000.00
CRCT income_statement (annual, 2023-12-31) — Gross Profit: 343293000.00
CRCT cash_flow (annual, 2023-12-31) — Income Tax Paid Supplemental Data: 24072000.00
CRCT income_statement (annual, 2023-12-31) — Interest Expense: 323000.00
CRCT income_statement (annual, 2023-12-31) — Interest Expense Non Operating: 323000.00
CRCT income_statement (annual, 2023-12-31) — Interest Income: 7976000.00
CRCT income_statement (annual, 2023-12-31) — Interest Income Non Operating: 7976000.00
CRCT cash_flow (annual, 2023-12-31) — Interest Paid Supplemental Data: 0.00
CRCT balance_sheet (annual, 2023-12-31) — Inventory: 244469000.00
CRCT balance_sheet (annual, 2023-12-31) — Invested Capital: 534873000.00
CRCT cash_flow (annual, 2023-12-31) — Investing Cash Flow: -48778000.00
CRCT cash_flow (annual, 2023-12-31) — Issuance Of Capital Stock: 0.00
CRCT balance_sheet (annual, 2023-12-31) — Leases: 5070000.00
CRCT balance_sheet (annual, 2023-12-31) — Long Term Capital Lease Obligation: 8938000.00
CRCT balance_sheet (annual, 2023-12-31) — Long Term Debt And Capital Lease Obligation: 8938000.00
CRCT balance_sheet (annual, 2023-12-31) — Machinery Furniture Equipment: 109530000.00
CRCT cash_flow (annual, 2023-12-31) — Net Common Stock Issuance: -20332000.00
CRCT cash_flow (annual, 2023-12-31) — Net Foreign Currency Exchange Gain Loss: 88000.00
CRCT income_statement (annual, 2023-12-31) — Net Income: 53636000.00
CRCT income_statement (annual, 2023-12-31) — Net Income Common Stockholders: 53636000.00
CRCT income_statement (annual, 2023-12-31) — Net Income Continuous Operations: 53636000.00
CRCT income_statement (annual, 2023-12-31) — Net Income From Continuing And Discontinued Operation: 53636000.00
CRCT income_statement (annual, 2023-12-31) — Net Income From Continuing Operation Net Minority Interest: 53636000.00
CRCT cash_flow (annual, 2023-12-31) — Net Income From Continuing Operations: 53636000.00
CRCT income_statement (annual, 2023-12-31) — Net Income Including Noncontrolling Interests: 53636000.00
CRCT income_statement (annual, 2023-12-31) — Net Interest Income: 7653000.00
CRCT cash_flow (annual, 2023-12-31) — Net Investment Purchase And Sale: -25061000.00
CRCT income_statement (annual, 2023-12-31) — Net Non Operating Interest Income Expense: 7653000.00
CRCT cash_flow (annual, 2023-12-31) — Net Other Financing Charges: -8106000.00
CRCT balance_sheet (annual, 2023-12-31) — Net PPE: 59967000.00
CRCT cash_flow (annual, 2023-12-31) — Net PPE Purchase And Sale: -23717000.00
CRCT balance_sheet (annual, 2023-12-31) — Net Tangible Assets: 534873000.00
CRCT balance_sheet (annual, 2023-12-31) — Non Current Deferred Assets: 34823000.00
CRCT balance_sheet (annual, 2023-12-31) — Non Current Deferred Liabilities: 2931000.00
CRCT balance_sheet (annual, 2023-12-31) — Non Current Deferred Revenue: 2931000.00
CRCT balance_sheet (annual, 2023-12-31) — Non Current Deferred Taxes Assets: 34823000.00
CRCT income_statement (annual, 2023-12-31) — Normalized EBITDA: 110145000.00
CRCT income_statement (annual, 2023-12-31) — Normalized Income: 53636000.00
CRCT cash_flow (annual, 2023-12-31) — Operating Cash Flow: 288097000.00
CRCT cash_flow (annual, 2023-12-31) — Operating Gains Losses: 88000.00
CRCT income_statement (annual, 2023-12-31) — Operating Income: 69985000.00
CRCT income_statement (annual, 2023-12-31) — Operating Revenue: 765147000.00
CRCT balance_sheet (annual, 2023-12-31) — Ordinary Shares Number: 217915713.00
CRCT balance_sheet (annual, 2023-12-31) — Other Current Assets: 19114000.00
CRCT balance_sheet (annual, 2023-12-31) — Other Current Liabilities: 41454000.00
CRCT balance_sheet (annual, 2023-12-31) — Other Equity Adjustments: 277000.00
CRCT income_statement (annual, 2023-12-31) — Other Gand A: 85091000.00
CRCT income_statement (annual, 2023-12-31) — Other Income Expense: 2145000.00
CRCT cash_flow (annual, 2023-12-31) — Other Non Cash Items: 2844000.00
CRCT balance_sheet (annual, 2023-12-31) — Other Non Current Assets: 35363000.00
CRCT balance_sheet (annual, 2023-12-31) — Other Non Current Liabilities: 6916000.00
CRCT income_statement (annual, 2023-12-31) — Other Non Operating Income Expenses: 2145000.00
CRCT balance_sheet (annual, 2023-12-31) — Other Properties: 34350000.00
CRCT balance_sheet (annual, 2023-12-31) — Other Receivables: 13127000.00
CRCT balance_sheet (annual, 2023-12-31) — Other Short Term Investments: 102952000.00
CRCT balance_sheet (annual, 2023-12-31) — Payables: 78997000.00
CRCT balance_sheet (annual, 2023-12-31) — Payables And Accrued Expenses: 150930000.00
CRCT balance_sheet (annual, 2023-12-31) — Preferred Stock: 0.00
CRCT income_statement (annual, 2023-12-31) — Pretax Income: 79783000.00
CRCT cash_flow (annual, 2023-12-31) — Proceeds From Stock Option Exercised: 383000.00
CRCT balance_sheet (annual, 2023-12-31) — Properties: 0.00
CRCT cash_flow (annual, 2023-12-31) — Provisionand Write Offof Assets: 26330000.00
CRCT cash_flow (annual, 2023-12-31) — Purchase Of Investment: -63451000.00
CRCT cash_flow (annual, 2023-12-31) — Purchase Of PPE: -23717000.00
CRCT balance_sheet (annual, 2023-12-31) — Receivables: 111247000.00
CRCT balance_sheet (annual, 2023-12-31) — Receivables Adjustments Allowances: -1950000.00
CRCT income_statement (annual, 2023-12-31) — Reconciled Cost Of Revenue: 421854000.00
CRCT income_statement (annual, 2023-12-31) — Reconciled Depreciation: 30039000.00
CRCT cash_flow (annual, 2023-12-31) — Repurchase Of Capital Stock: -20332000.00
CRCT income_statement (annual, 2023-12-31) — Research And Development: 65048000.00
CRCT balance_sheet (annual, 2023-12-31) — Retained Earnings: 28514000.00
CRCT cash_flow (annual, 2023-12-31) — Sale Of Investment: 38390000.00
CRCT income_statement (annual, 2023-12-31) — Selling And Marketing Expense: 123169000.00
CRCT income_statement (annual, 2023-12-31) — Selling General And Administration: 208260000.00
CRCT balance_sheet (annual, 2023-12-31) — Share Issued: 217915713.00
CRCT cash_flow (annual, 2023-12-31) — Stock Based Compensation: 47326000.00
CRCT balance_sheet (annual, 2023-12-31) — Stockholders Equity: 534873000.00
CRCT balance_sheet (annual, 2023-12-31) — Tangible Book Value: 534873000.00
CRCT income_statement (annual, 2023-12-31) — Tax Effect Of Unusual Items: 0.00
CRCT income_statement (annual, 2023-12-31) — Tax Provision: 26147000.00
CRCT income_statement (annual, 2023-12-31) — Tax Rate For Calcs: 0.33
CRCT balance_sheet (annual, 2023-12-31) — Total Assets: 750122000.00
CRCT balance_sheet (annual, 2023-12-31) — Total Capitalization: 534873000.00
CRCT balance_sheet (annual, 2023-12-31) — Total Debt: 14168000.00
CRCT balance_sheet (annual, 2023-12-31) — Total Equity Gross Minority Interest: 534873000.00
CRCT income_statement (annual, 2023-12-31) — Total Expenses: 695162000.00
CRCT balance_sheet (annual, 2023-12-31) — Total Liabilities Net Minority Interest: 215249000.00
CRCT balance_sheet (annual, 2023-12-31) — Total Non Current Assets: 130153000.00
CRCT balance_sheet (annual, 2023-12-31) — Total Non Current Liabilities Net Minority Interest: 18785000.00
CRCT income_statement (annual, 2023-12-31) — Total Operating Income As Reported: 69985000.00
CRCT balance_sheet (annual, 2023-12-31) — Treasury Shares Number: 0.00
CRCT balance_sheet (annual, 2023-12-31) — Working Capital: 423505000.00
CRCT balance_sheet (quarterly, 2024-09-30) — Allowance For Doubtful Accounts Receivable: -1100000.00
CRCT cash_flow (quarterly, 2024-09-30) — Interest Paid Supplemental Data: 0.00
CRCT cash_flow (quarterly, 2024-09-30) — Proceeds From Stock Option Exercised: 0.00
CRCT income_statement (annual, 2024-12-31) — +Operating Expense: 276678000.00
CRCT income_statement (annual, 2024-12-31) — +Total Revenue: 712538000.00
CRCT balance_sheet (annual, 2024-12-31) — Accounts Payable: 53373000.00
CRCT balance_sheet (annual, 2024-12-31) — Accounts Receivable: 90665000.00
CRCT balance_sheet (annual, 2024-12-31) — Accumulated Depreciation: -123647000.00
CRCT balance_sheet (quarterly, 2024-12-31) — Accumulated Depreciation: -123647000.00
CRCT balance_sheet (annual, 2024-12-31) — Additional Paid In Capital: 466554000.00
CRCT cash_flow (annual, 2024-12-31) — Asset Impairment Charge: 3771000.00
CRCT income_statement (annual, 2024-12-31) — Basic Average Shares: 215105815.00
CRCT income_statement (annual, 2024-12-31) — Basic EPS: 0.29
CRCT cash_flow (annual, 2024-12-31) — Beginning Cash Position: 142187000.00
CRCT balance_sheet (annual, 2024-12-31) — Buildings And Improvements: 13958000.00
CRCT balance_sheet (quarterly, 2024-12-31) — Buildings And Improvements: 13958000.00
CRCT cash_flow (annual, 2024-12-31) — Capital Expenditure: -18334000.00
CRCT balance_sheet (annual, 2024-12-31) — Capital Lease Obligations: 15209000.00
CRCT balance_sheet (annual, 2024-12-31) — Capital Stock: 213000.00
CRCT balance_sheet (annual, 2024-12-31) — Cash And Cash Equivalents: 232140000.00
CRCT balance_sheet (annual, 2024-12-31) — Cash Cash Equivalents And Short Term Investments: 336914000.00
CRCT cash_flow (annual, 2024-12-31) — Cash Dividends Paid: -109972000.00
CRCT balance_sheet (annual, 2024-12-31) — Cash Equivalents: 70892000.00
CRCT balance_sheet (annual, 2024-12-31) — Cash Financial: 161248000.00
CRCT cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Financing Activities: -156435000.00
CRCT cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Investing Activities: -18328000.00
CRCT cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Operating Activities: 264968000.00
CRCT cash_flow (annual, 2024-12-31) — Change In Account Payable: -23120000.00
CRCT cash_flow (annual, 2024-12-31) — Change In Accrued Expense: 6985000.00
CRCT cash_flow (annual, 2024-12-31) — Change In Inventory: 149965000.00
CRCT cash_flow (annual, 2024-12-31) — Change In Other Current Assets: -1119000.00
CRCT cash_flow (annual, 2024-12-31) — Change In Other Current Liabilities: -5365000.00
CRCT cash_flow (annual, 2024-12-31) — Change In Other Working Capital: 5018000.00
CRCT cash_flow (annual, 2024-12-31) — Change In Payable: -23120000.00
CRCT cash_flow (annual, 2024-12-31) — Change In Payables And Accrued Expense: -16135000.00
CRCT cash_flow (annual, 2024-12-31) — Change In Prepaid Assets: -7221000.00
CRCT cash_flow (annual, 2024-12-31) — Change In Receivables: 4888000.00
CRCT cash_flow (annual, 2024-12-31) — Change In Working Capital: 130031000.00
CRCT cash_flow (annual, 2024-12-31) — Changes In Account Receivables: 4888000.00
CRCT cash_flow (annual, 2024-12-31) — Changes In Cash: 90205000.00
CRCT balance_sheet (annual, 2024-12-31) — Common Stock: 213000.00
CRCT cash_flow (annual, 2024-12-31) — Common Stock Dividend Paid: -109972000.00
CRCT balance_sheet (annual, 2024-12-31) — Common Stock Equity: 466761000.00
CRCT cash_flow (annual, 2024-12-31) — Common Stock Payments: -38493000.00
CRCT balance_sheet (annual, 2024-12-31) — Construction In Progress: 1528000.00
CRCT balance_sheet (quarterly, 2024-12-31) — Construction In Progress: 1528000.00
CRCT income_statement (annual, 2024-12-31) — Cost Of Revenue: 359750000.00
CRCT balance_sheet (annual, 2024-12-31) — Current Accrued Expenses: 76274000.00
CRCT balance_sheet (annual, 2024-12-31) — Current Assets: 580214000.00
CRCT balance_sheet (annual, 2024-12-31) — Current Capital Lease Obligation: 3899000.00
CRCT balance_sheet (annual, 2024-12-31) — Current Debt And Capital Lease Obligation: 3899000.00
CRCT balance_sheet (annual, 2024-12-31) — Current Deferred Liabilities: 45427000.00
CRCT balance_sheet (annual, 2024-12-31) — Current Deferred Revenue: 45427000.00
CRCT balance_sheet (annual, 2024-12-31) — Current Liabilities: 203374000.00
CRCT cash_flow (annual, 2024-12-31) — Deferred Income Tax: -4378000.00
CRCT cash_flow (annual, 2024-12-31) — Deferred Tax: -4378000.00
CRCT cash_flow (annual, 2024-12-31) — Depreciation Amortization Depletion: 29006000.00
CRCT cash_flow (annual, 2024-12-31) — Depreciation And Amortization: 29006000.00
CRCT income_statement (annual, 2024-12-31) — Diluted Average Shares: 215645506.00
CRCT income_statement (annual, 2024-12-31) — Diluted EPS: 0.29
CRCT income_statement (annual, 2024-12-31) — Diluted NI Availto Com Stockholders: 62830000.00
CRCT balance_sheet (annual, 2024-12-31) — Dividends Payable: 24401000.00
CRCT income_statement (annual, 2024-12-31) — EBIT: 89203000.00
CRCT income_statement (annual, 2024-12-31) — EBITDA: 118209000.00
CRCT cash_flow (annual, 2024-12-31) — Effect Of Exchange Rate Changes: -252000.00
CRCT cash_flow (annual, 2024-12-31) — End Cash Position: 232140000.00
CRCT cash_flow (annual, 2024-12-31) — Financing Cash Flow: -156435000.00
CRCT cash_flow (annual, 2024-12-31) — Free Cash Flow: 246634000.00
CRCT balance_sheet (annual, 2024-12-31) — Gains Losses Not Affecting Retained Earnings: -6000.00
CRCT income_statement (annual, 2024-12-31) — General And Administrative Expense: 72985000.00
CRCT balance_sheet (annual, 2024-12-31) — Gross Accounts Receivable: 90665000.00
CRCT balance_sheet (annual, 2024-12-31) — Gross PPE: 175151000.00
CRCT income_statement (annual, 2024-12-31) — Gross Profit: 352788000.00
CRCT cash_flow (annual, 2024-12-31) — Income Tax Paid Supplemental Data: 43596000.00
CRCT cash_flow (quarterly, 2024-12-31) — Income Tax Paid Supplemental Data: 8698000.00
CRCT income_statement (annual, 2024-12-31) — Interest Expense: 326000.00
CRCT income_statement (annual, 2024-12-31) — Interest Expense Non Operating: 326000.00
CRCT income_statement (annual, 2024-12-31) — Interest Income: 11016000.00
CRCT income_statement (annual, 2024-12-31) — Interest Income Non Operating: 11016000.00
CRCT cash_flow (annual, 2024-12-31) — Interest Paid Supplemental Data: 0.00
CRCT cash_flow (quarterly, 2024-12-31) — Interest Paid Supplemental Data: 0.00
CRCT balance_sheet (annual, 2024-12-31) — Inventory: 115255000.00
CRCT balance_sheet (annual, 2024-12-31) — Invested Capital: 466761000.00
CRCT cash_flow (annual, 2024-12-31) — Investing Cash Flow: -18328000.00
CRCT balance_sheet (annual, 2024-12-31) — Leases: 5073000.00
CRCT balance_sheet (quarterly, 2024-12-31) — Leases: 5073000.00
CRCT balance_sheet (annual, 2024-12-31) — Long Term Capital Lease Obligation: 11310000.00
CRCT balance_sheet (annual, 2024-12-31) — Long Term Debt And Capital Lease Obligation: 11310000.00
CRCT balance_sheet (annual, 2024-12-31) — Machinery Furniture Equipment: 118869000.00
CRCT balance_sheet (quarterly, 2024-12-31) — Machinery Furniture Equipment: 118869000.00
CRCT cash_flow (annual, 2024-12-31) — Net Common Stock Issuance: -38493000.00
CRCT cash_flow (annual, 2024-12-31) — Net Foreign Currency Exchange Gain Loss: 1047000.00
CRCT income_statement (annual, 2024-12-31) — Net Income: 62830000.00
CRCT income_statement (annual, 2024-12-31) — Net Income Common Stockholders: 62830000.00
CRCT income_statement (annual, 2024-12-31) — Net Income Continuous Operations: 62830000.00
CRCT income_statement (annual, 2024-12-31) — Net Income From Continuing And Discontinued Operation: 62830000.00
CRCT income_statement (annual, 2024-12-31) — Net Income From Continuing Operation Net Minority Interest: 62830000.00
CRCT cash_flow (annual, 2024-12-31) — Net Income From Continuing Operations: 62830000.00
CRCT income_statement (annual, 2024-12-31) — Net Income Including Noncontrolling Interests: 62830000.00
CRCT income_statement (annual, 2024-12-31) — Net Interest Income: 10690000.00
CRCT cash_flow (annual, 2024-12-31) — Net Investment Purchase And Sale: 6000.00
CRCT cash_flow (quarterly, 2024-12-31) — Net Investment Purchase And Sale: 0.00
CRCT income_statement (annual, 2024-12-31) — Net Non Operating Interest Income Expense: 10690000.00
CRCT cash_flow (annual, 2024-12-31) — Net Other Financing Charges: -7970000.00
CRCT balance_sheet (annual, 2024-12-31) — Net PPE: 51504000.00
CRCT cash_flow (annual, 2024-12-31) — Net PPE Purchase And Sale: -18334000.00
CRCT balance_sheet (annual, 2024-12-31) — Net Tangible Assets: 466761000.00
CRCT balance_sheet (annual, 2024-12-31) — Non Current Deferred Assets: 39186000.00
CRCT balance_sheet (annual, 2024-12-31) — Non Current Deferred Liabilities: 2826000.00
CRCT balance_sheet (annual, 2024-12-31) — Non Current Deferred Revenue: 2826000.00
CRCT balance_sheet (annual, 2024-12-31) — Non Current Deferred Taxes Assets: 39186000.00
CRCT income_statement (annual, 2024-12-31) — Normalized EBITDA: 118209000.00
CRCT income_statement (annual, 2024-12-31) — Normalized Income: 62830000.00
CRCT cash_flow (annual, 2024-12-31) — Operating Cash Flow: 264968000.00
CRCT cash_flow (annual, 2024-12-31) — Operating Gains Losses: 1047000.00
CRCT income_statement (annual, 2024-12-31) — Operating Income: 76110000.00
CRCT income_statement (annual, 2024-12-31) — Operating Revenue: 712538000.00
CRCT balance_sheet (annual, 2024-12-31) — Ordinary Shares Number: 213295922.00
CRCT balance_sheet (annual, 2024-12-31) — Other Current Assets: 26065000.00
CRCT balance_sheet (annual, 2024-12-31) — Other Current Liabilities: 37518000.00
CRCT balance_sheet (quarterly, 2024-12-31) — Other Current Liabilities: 37518000.00
CRCT balance_sheet (annual, 2024-12-31) — Other Equity Adjustments: -6000.00
CRCT income_statement (annual, 2024-12-31) — Other Gand A: 72985000.00
CRCT income_statement (annual, 2024-12-31) — Other Income Expense: 2077000.00
CRCT cash_flow (annual, 2024-12-31) — Other Non Cash Items: 2995000.00
CRCT balance_sheet (annual, 2024-12-31) — Other Non Current Assets: 22131000.00
CRCT balance_sheet (annual, 2024-12-31) — Other Non Current Liabilities: 8764000.00
CRCT income_statement (annual, 2024-12-31) — Other Non Operating Income Expenses: 2077000.00
CRCT balance_sheet (annual, 2024-12-31) — Other Properties: 35723000.00
CRCT balance_sheet (annual, 2024-12-31) — Other Receivables: 13932000.00
CRCT balance_sheet (quarterly, 2024-12-31) — Other Receivables: 13932000.00
CRCT balance_sheet (annual, 2024-12-31) — Other Short Term Investments: 104774000.00
CRCT balance_sheet (annual, 2024-12-31) — Payables: 77774000.00
CRCT balance_sheet (annual, 2024-12-31) — Payables And Accrued Expenses: 154048000.00
CRCT balance_sheet (annual, 2024-12-31) — Preferred Stock: 0.00
CRCT income_statement (annual, 2024-12-31) — Pretax Income: 88877000.00
CRCT cash_flow (annual, 2024-12-31) — Proceeds From Stock Option Exercised: 0.00
CRCT cash_flow (quarterly, 2024-12-31) — Proceeds From Stock Option Exercised: 0.00
CRCT balance_sheet (annual, 2024-12-31) — Properties: 0.00
CRCT balance_sheet (quarterly, 2024-12-31) — Properties: 0.00
CRCT cash_flow (annual, 2024-12-31) — Provisionand Write Offof Assets: -5401000.00
CRCT cash_flow (annual, 2024-12-31) — Purchase Of Investment: -110521000.00
CRCT cash_flow (quarterly, 2024-12-31) — Purchase Of Investment: 0.00
CRCT cash_flow (annual, 2024-12-31) — Purchase Of PPE: -18334000.00
CRCT balance_sheet (annual, 2024-12-31) — Receivables: 101980000.00
CRCT balance_sheet (annual, 2024-12-31) — Receivables Adjustments Allowances: -2617000.00
CRCT balance_sheet (quarterly, 2024-12-31) — Receivables Adjustments Allowances: -2617000.00
CRCT income_statement (annual, 2024-12-31) — Reconciled Cost Of Revenue: 359750000.00
CRCT income_statement (annual, 2024-12-31) — Reconciled Depreciation: 29006000.00
CRCT cash_flow (annual, 2024-12-31) — Repurchase Of Capital Stock: -38493000.00
CRCT income_statement (annual, 2024-12-31) — Research And Development: 60399000.00
CRCT balance_sheet (annual, 2024-12-31) — Retained Earnings: 0.00
CRCT cash_flow (annual, 2024-12-31) — Sale Of Investment: 110527000.00
CRCT cash_flow (quarterly, 2024-12-31) — Sale Of Investment: 0.00
CRCT income_statement (annual, 2024-12-31) — Selling And Marketing Expense: 143294000.00
CRCT income_statement (annual, 2024-12-31) — Selling General And Administration: 216279000.00
CRCT balance_sheet (annual, 2024-12-31) — Share Issued: 213295922.00
CRCT cash_flow (annual, 2024-12-31) — Stock Based Compensation: 45067000.00
CRCT balance_sheet (annual, 2024-12-31) — Stockholders Equity: 466761000.00
CRCT balance_sheet (annual, 2024-12-31) — Tangible Book Value: 466761000.00
CRCT income_statement (annual, 2024-12-31) — Tax Effect Of Unusual Items: 0.00
CRCT income_statement (annual, 2024-12-31) — Tax Provision: 26047000.00
CRCT income_statement (annual, 2024-12-31) — Tax Rate For Calcs: 0.29
CRCT balance_sheet (annual, 2024-12-31) — Total Assets: 693035000.00
CRCT balance_sheet (annual, 2024-12-31) — Total Capitalization: 466761000.00
CRCT balance_sheet (annual, 2024-12-31) — Total Debt: 15209000.00
CRCT balance_sheet (annual, 2024-12-31) — Total Equity Gross Minority Interest: 466761000.00
CRCT income_statement (annual, 2024-12-31) — Total Expenses: 636428000.00
CRCT balance_sheet (annual, 2024-12-31) — Total Liabilities Net Minority Interest: 226274000.00
CRCT balance_sheet (annual, 2024-12-31) — Total Non Current Assets: 112821000.00
CRCT balance_sheet (annual, 2024-12-31) — Total Non Current Liabilities Net Minority Interest: 22900000.00
CRCT income_statement (annual, 2024-12-31) — Total Operating Income As Reported: 76110000.00
CRCT balance_sheet (annual, 2024-12-31) — Working Capital: 376840000.00
CRCT income_statement (quarterly, 2025-03-31) — +Operating Expense: 69007000.00
CRCT income_statement (quarterly, 2025-03-31) — +Total Revenue: 162634000.00
CRCT balance_sheet (quarterly, 2025-03-31) — Accounts Payable: 58269000.00
CRCT balance_sheet (quarterly, 2025-03-31) — Accounts Receivable: 72325000.00
CRCT balance_sheet (quarterly, 2025-03-31) — Additional Paid In Capital: 463754000.00
CRCT balance_sheet (quarterly, 2025-03-31) — Allowance For Doubtful Accounts Receivable: -1300000.00
CRCT cash_flow (quarterly, 2025-03-31) — Asset Impairment Charge: -1903000.00
CRCT income_statement (quarterly, 2025-03-31) — Basic Average Shares: 212445961.00
CRCT income_statement (quarterly, 2025-03-31) — Basic EPS: 0.11
CRCT cash_flow (quarterly, 2025-03-31) — Beginning Cash Position: 232140000.00
CRCT cash_flow (quarterly, 2025-03-31) — Capital Expenditure: -4892000.00
CRCT balance_sheet (quarterly, 2025-03-31) — Capital Lease Obligations: 14507000.00
CRCT balance_sheet (quarterly, 2025-03-31) — Capital Stock: 212000.00
CRCT balance_sheet (quarterly, 2025-03-31) — Cash And Cash Equivalents: 252141000.00
CRCT balance_sheet (quarterly, 2025-03-31) — Cash Cash Equivalents And Short Term Investments: 356668000.00
CRCT cash_flow (quarterly, 2025-03-31) — Cash Dividends Paid: -21493000.00
CRCT balance_sheet (quarterly, 2025-03-31) — Cash Equivalents: 125354000.00
CRCT balance_sheet (quarterly, 2025-03-31) — Cash Financial: 126787000.00
CRCT cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Financing Activities: -36417000.00
CRCT cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Investing Activities: -4892000.00
CRCT cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Operating Activities: 61166000.00
CRCT cash_flow (quarterly, 2025-03-31) — Change In Account Payable: 4895000.00
CRCT cash_flow (quarterly, 2025-03-31) — Change In Accrued Expense: -19979000.00
CRCT cash_flow (quarterly, 2025-03-31) — Change In Inventory: 4877000.00
CRCT cash_flow (quarterly, 2025-03-31) — Change In Other Current Assets: -3125000.00
CRCT cash_flow (quarterly, 2025-03-31) — Change In Other Current Liabilities: -1074000.00
CRCT cash_flow (quarterly, 2025-03-31) — Change In Other Working Capital: 5521000.00
CRCT cash_flow (quarterly, 2025-03-31) — Change In Payable: 4895000.00
CRCT cash_flow (quarterly, 2025-03-31) — Change In Payables And Accrued Expense: -15084000.00
CRCT cash_flow (quarterly, 2025-03-31) — Change In Prepaid Assets: 8662000.00
CRCT cash_flow (quarterly, 2025-03-31) — Change In Receivables: 32213000.00
CRCT cash_flow (quarterly, 2025-03-31) — Change In Working Capital: 31990000.00
CRCT cash_flow (quarterly, 2025-03-31) — Changes In Account Receivables: 32213000.00
CRCT cash_flow (quarterly, 2025-03-31) — Changes In Cash: 19857000.00
CRCT balance_sheet (quarterly, 2025-03-31) — Common Stock: 212000.00
CRCT cash_flow (quarterly, 2025-03-31) — Common Stock Dividend Paid: -21493000.00
CRCT balance_sheet (quarterly, 2025-03-31) — Common Stock Equity: 490174000.00
CRCT cash_flow (quarterly, 2025-03-31) — Common Stock Payments: -12000000.00
CRCT income_statement (quarterly, 2025-03-31) — Cost Of Revenue: 64286000.00
CRCT balance_sheet (quarterly, 2025-03-31) — Current Accrued Expenses: 57793000.00
CRCT balance_sheet (quarterly, 2025-03-31) — Current Assets: 561234000.00
CRCT balance_sheet (quarterly, 2025-03-31) — Current Capital Lease Obligation: 3815000.00